Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on September 2, 2025
Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
PARIS and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for …
Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment
GlobeNewswire
·
September 2, 2025
PARIS et CAMBRIDGE, Mass., 02 sept. 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur les …
Microchip Technology to Present at the Citi 2025 Global TMT Conference
GlobeNewswire
·
September 2, 2025
CHANDLER, Arizona, Sept. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Citi 2025 Global …
Certara to Participate in Upcoming Investor Conferences
GlobeNewswire
·
September 2, 2025
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: Baird Global Healthcare …
Cycurion to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a premier cybersecurity and IT solutions provider announces that its Chief Executive Officer, Kevin Kelly, and Chief Financial Officer, Alvin McCoy, …
Lifecore Biomedical to Participate in Upcoming Investor Conferences
GlobeNewswire
·
September 2, 2025
CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming …
Diginex Announces move into Digital Asset Sustainability Project Verification; Signs Strategic Alliance with BlockRidge
GlobeNewswire
·
September 2, 2025
LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX) (“Diginex”), a leading provider of Sustainability RegTech solutions, and Valuit Technology Delaware LLC (hereinafter referred to as “BlockRidge”), a leading provider of tokenization …
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
Berkeley, Calif, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an …
Lyell Immunopharma Announces Participation in September Investor Conferences
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing next-generation CAR T-cell therapies for patients with cancer, …
Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 2, 2025
FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and Chief …
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
CarGurus to Present at the 2025 Goldman Sachs Communacopia + Technology Conference
GlobeNewswire
·
September 2, 2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced that Jason Trevisan, Chief Executive Officer, is scheduled to …
Zscaler Reports Fourth Quarter and Fiscal 2025 Financial Results
GlobeNewswire
·
September 2, 2025
Fourth Quarter Highlights Revenue grows 21% year-over-year to $719.2 million Annual Recurring Revenue ("ARR") grows 22% year-over-year to $3,015 million Calculated billings grows 32% year-over-year to $1,202.3 million Deferred revenue grows 30% year-over- …
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
Rackspace Technology Names Gajen Kandiah Chief Executive Officer
GlobeNewswire
·
September 2, 2025
SAN ANTONIO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a global provider of hybrid cloud and AI solutions, today announced that its Board of Directors has appointed Gajen Kandiah as Chief Executive Officer, effective September …
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 2, 2025
WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial …
Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025
GlobeNewswire
·
September 2, 2025
COPENHAGEN, Denmark, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced three oral presentations of its latest achondroplasia and hypoparathyroidism data at ASBMR 2025, the annual meeting of the American Society for Bone …
Mineralys Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
September 2, 2025
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …
Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812)
GlobeNewswire
·
September 2, 2025
PURCHASE, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, closed its previously announced registered …
Trasna and CardNet alliance targets SIM market in Latin America
EIN Presswire
·
September 2, 2025
DUBAI, UNITED ARAB EMIRATES, September 2, 2025 /EINPresswire.com/ -- Dubai and São Paulo: Trasna, the global semiconductor and IoT provider, and CardNet, a leading smart card manufacturer in Brazil, have announced a strategic partnership to produce a new …